mynth
← DATABASE
11/2025

EXCELLENCE IMAGERIE acquired by METRIC CAPITAL PARTNERS

FRANCE Health Providers / Outpatient Care / Radiology EV 300M - 700M EUR

Context

The Paris-based radiology group with approximately EUR80 million in revenue, backed since 2019 by UI Investissement, has just concluded a second LBO under the impetus of Metric Capital Partners, which would value it between EUR350 million and EUR400 million, according to our information, a little over a year after the abandonment of its takeover by Antin IP.

EXCELLENCE IMAGERIE, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a level LOGIN the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded in 2019, Excellence Imagerie brings together the expertise of three leading medical imaging centers: the Institut de Radiologie de Paris (IRP), the Centre de Senologie et d Echographie (CSE), and Imagerie Medicale Faidherbe Mont-Louis (IMFM). The project aims to build a group driven by a strong medical ambition: to gather and retain the best practitioners and healthcare staff (medical secretaries and radiographers), to provide technical platforms equipped with the latest generation of technology, and to deliver high-level service by placing the patient at the heart of the care process.

Ent. Value

LOGIN

Equity Value

LOGIN

Multiples

EV / Revenue

LOGIN

EV / EBITDA

LOGIN

EV / EBIT

LOGIN

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2024
LOGIN
LOGIN
LOGIN
2023
LOGIN
LOGIN
LOGIN

Similar deals in Healthcare & Pharma

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
DateAcquirerTargetCountrySectorDeal Context
01/2026GTCRDENTALCORPCanadaHealth Providers

Dentalcorp Holdings Ltd. has successfully completed a statutory plan of arrangement to be acquired by an acquisition vehicle affiliated with GTCR. Under the terms of the agreement, GTCR acquired all issued and outstanding subordinate and multiple voting shares for C$11.00 per share in cash. The transaction represents a premium of approximately 33% over the 20,day volume weighted average trading price prior to the initial announcement in September 2025. Following the completion of the deal, the company is expected to be de,listed from the Toronto Stock Exchange and will cease to be a reporting issuer in Canada

12/2025TERVEYSTALO HEALTHCAREHOHDE GROUPFINLANDHealth Providers

Terveystalo signed an agreement to acquire Hohde Group, comprising Hammas Hohde Oy and Loisto Laboratoriot Oy, in a transaction financed through debt committed by Terveystalo's existing partner banks. The acquisition is subject to approval by the Finnish Competition and Consumer Authority. The transaction directly supports Terveystalo's stated strategic objective of doubling its oral health business and becoming one of Finland's leading oral health companies, as communicated at its 2024 Capital Markets Day

11/2025CIR - COMPAGNIE INDUSTRIALI RIUNITEKOS GROUPITALYHealth Providers

CIR has signed a binding agreement to acquire the remaining 40.23% stake in KOS Group from F2i Healthcare (controlled by F2i Sgr and its co-investors), moving to 100% ownership. The strategic rationale for the transaction is to consolidate full industrial control over CIR's most strategic asset, enabling simplified governance and a more agile execution of KOS's expansion plans in Italy and Germany. By deploying its available cash reserves, CIR eliminates minority leakage and positions itself to capture the full upside of KOS’s performance recovery

10/2025GROUPE RESONANCE IMAGERIECIMEPFRANCEHealth Providers

Groupe Resonance Imagerie, a french medical imaging group supported by Andera Partners for the past three years, is pursuing its geographical consolidation strategy by acquiring the Parisian company Cimep, which brings it 12 centers and nearly EUR20 million in additional revenue. The organization operates as a high-fidelity practitioner-led platform, focusing on the seamless integration of radiology expertise with advanced medical imaging technologies. Rather than focusing solely on basic diagnostics, the firm thrives on a philosophy of technical operational depth, managing a distributed network of centers that provide high-capacity scanning, MRI, and ultrasound services

07/2025BRIDGEPOINTMYDENTISTUNITED KINGDOMHealth Providers

Bridgepoint acquired MyDentist from its long-term owners (likely Palamon Capital Partners and The Carlyle Group). Bridgepoint aims to accelerate the group's pivot from low-margin NHS contracts toward high-growth private treatments (implants, aesthetics, clear aligners). Leveraging its prior success with Oasis Dental Care, Bridgepoint plans to implement a rigorous operational efficiency program, utilizing digitalization and AI to optimize chair utilization and patient triage. Furthermore, MyDentist will serve as a consolidation platform, aggressively acquiring smaller independent practices to realize economies of scale in a fragmented market

05/2025FONDATION SANTE SERVICECLARIANE HAD (HOME HOSPITALIZATION SERVICES)FRANCEHealth Providers

Clariane sells its French home hospitalization business to the leader of the sector in France, Fondation Sante Service. The deal is part of Clariane's EUR1bn asset disposal plan to strengthen its balance sheet.

04/2025EUROFINS SCIENTIFICSYNLAB SPAINSPAINHealth Providers

Eurofins Scientific has completed the acquisition of 100% of SYNLAB’s clinical diagnostics operations in Spain. The transaction, initially agreed upon in October 2024, was finalized on March 31, 2025. This strategic carve-out allows SYNLAB to optimize its portfolio by exiting the Spanish market to focus on regions with higher strategic impact. For Eurofins, the acquisition is transformative, merging SYNLAB’s assets with its existing Eurofins Megalab network to become the undisputed leader in clinical diagnostics in Spain

12/2024SONIC HEALTHCARELADR – LABORATORY GROUP DR. KRAMER & COLLEAGUESGERMANYHealth Providers

Sonic Healthcare has signed binding agreements to acquire the LADR Laboratory Group, marking a substantial expansion of its German and European diagnostic footprint. The transaction was structured on a cash and debt-free basis, with a total consideration satisfied through a mix of Sonic ordinary shares (up to 222 million euros) and cash funded from existing facilities. The strategic rationale centers on the strong cultural and operational alignment between the two organizations, with significant synergy potential identified in procurement, laboratory overlaps, logistics, and equipment maintenance

12/2024CAPZAIMDEVFRANCEHealth Providers

The transaction involves a primary Owner Buy-Out (OBO) where Capza and Bpifrance acquire a minority stake in Imdev to support its next phase of pan-European scaling. This capital injection includes a significant capital increase and a cash-out component for historical shareholders. The strategic rationale is centered on accelerating a nationwide build-up strategy, with a target of 15 to 30 additional acquisitions per year to double the group's size. Financially, the deal is supported by a unitranche debt facility provided by ICG, which was restructured to accommodate the group's new growth ambitions

11/2024GROUPE IMAGERIE CARDINETRADIOLOGIE PARIS OUESTFRANCEHealth Providers

Groupe Imagerie Cardinet acquired 100% of Radiologie Paris Ouest from its previous majority shareholder, Azulis Capital, which had held a stake since 2019. The transaction was financed with the support of Andera Acto (Andera Partners' sponsorless/mezzanine arm), which had already invested in Cardinet in 2023. A critical feature of the deal is the significant reinvestment by RPO's 20 radiologist-associates, who rolled over more than 50% of their proceeds into the combined holding company. This merger creates a major regional champion in the Ile-de-France area, with a combined pool of over 60 partner-physicians and a dense network of centers across Paris and its western and eastern suburbs

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 50M - 100M EUR

EBITDA range: 10M - 30M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of EXCELLENCE IMAGERIE by METRIC CAPITAL PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Target: excellence imagerie

Acquirer: metric capital partners